The Global Partnership for Zero Leprosy (GPZL) is a coalition committed to ending leprosy, also known as Hansen’s disease. Our members include individuals and organizations who share our triple-zero vision of no disease, no disability, and no discrimination or stigma.

Our Impact

  • organizational members
  • individual members
  • country partnerships
  • best practices

The Challenge

  • 200,000 people
    diagnosed each year
  • 5 million people
    living with leprosy-related disability and stigma
  • 150 countries
    with active transmission
  • 130 laws
    discriminate against people who have experienced leprosy

Our Strategy

  • Country Partnerships

    We partner with national leprosy programmes and provide technical assistance to create country-led, customized strategies that address local needs and priorities to end leprosy.

  • Research

    We convene experts to advance research priorities so we can reach zero leprosy faster.

  • Advocacy

    We coordinate action to advance zero leprosy in international agendas and increase resources to end leprosy worldwide.

learn more

Zero Leprosy Toolkit

The Zero Leprosy Toolkit is a free set of field-tested best practices designed to support countries in their work toward ending leprosy and its associated disabilities and stigma.

Browse all best practices

Upcoming Events

07 - 10 August

11th International Conference on Emerging Infectious Diseases (ICEID)

Read more >

13-15 September 2022

NNN Conference 2022

Read more >

Subscribe to Newsletter

Receive monthly updates on our progress toward zero leprosy and opportunities to get involved.

Sign up

Recent News

22 February 2022

Call for Nominations: 7 Representatives to join Leadership Team

The Global Partnership for Zero Leprosy seeks to expand its Leadership Team. Seven positions are open for nominations, including two representatives of persons-affected organizations, two representatives of National Leprosy Programmes, one organizational member representative, one individual member representative, and one global health representative. Descriptions of … Read More >